Navigation Links
Independent Expert Panel Calls for Information on Fragrance Ingredients Under Review
Date:8/4/2011

WOODCLIFF LAKE, N. J., Aug. 4, 2011 /PRNewswire-USNewswire/ -- An independent Expert Panel of interdisciplinary scientists is calling for information on fragrance ingredients from the RIFM Human Health Group Summary on alkyl cyclic ketones. The Expert Panel will review this group in September 2011. Materials representative of this group are:

(Logo: http://photos.prnewswire.com/prnh/20101215/DC17717LOGO)

1-(3,3-Dimethylcyclohexyl)ethan-1-one - CAS# 25304-14-7

Methyl 2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl ketone - CAS# 28371-99-5

1-(1,2,3,4,5,6,7,8-Octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)ethanone - CAS#'s 54464-57-2, 68155-66-8, 68155-67-9

1-(5,5-Dimethyl-1-cyclohexen-1-yl)pent-4-en-1-one - CAS# 56973-85-4

Acetyl cedrene - CAS# 32388-55-9

1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)pent-1-en-3-one - CAS# 7779-30-8

Information regarding these fragrance materials should be submitted by e-mail to Dr. Ladd Smith, smith@rifm.org, by August 25, 2011 to be considered for the September 2011 meeting. A request to present information in-person, if desired, should be included in the e-mail to Dr. Smith. Information received from interested parties, will be included as part of the background assembled for discussion of these items. Interested party submissions will undergo a formal review and presenters should be willing and prepared to answer questions from the Panel.

The global fragrance industry collectively carries out research on fragrance ingredients through RIFM. An independent, third-party Expert Panel regularly reviews RIFM's research and publishes their evaluations in the peer-reviewed scientific literature available publicly. The Expert Panel opened its process to the public to increase awareness of its activities and enhance dialogue with interested parties. All members of the Expert Panel are listed on the RIFM web site at www.rifm.org along with information on the Panel's meetings.

RIFM is the international scientific authority for the safe use of fragrance materials. RIFM generates, evaluates and distributes scientific data on the safety assessment of fragrance raw materials found in personal and household care products. Through extensive research, testing and constant monitoring of all scientific literature available, RIFM maintains its Database as the most comprehensive source worldwide of physical-chemical, toxicological and eco-toxicological data associated with known fragrance and flavor materials. All of RIFM's scientific findings are evaluated by an independent Expert Panel — an international group of dermatologists, pathologists, toxicologists, respiratory and environmental scientists. The Expert Panel evaluates the safety of fragrance ingredients under conditions of intended use and publishes their results in peer-reviewed scientific journals. The decisions of the Expert Panel regarding restrictions of use are also published in the IFRA Standards. For more information about RIFM and its activities, visit www.rifm.org or e-mail rifm@rifm.org.

Contact: Marie Gartshore, Communications Manager
e-mail: mgartshore@rifm.org
tel: 201.689.8089, ext. 111


'/>"/>
SOURCE Research Institute for Fragrance Materials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
3. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
4. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
5. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
6. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
7. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
8. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Promise of Vicals CMV Vaccine Noted by Independent Experts
11. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...
(Date:10/11/2017)... Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... facility in Las Piedras, Puerto Rico ... blades. Following ... facility sustained minor structural damage, temporary loss of power ... have been completed, manufacturing operations have resumed, and the ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):